EUROPE INFERTILITY TESTING AND TREATMENT MARKET 2021-2028

Lifesciences | Diagnostic & Biotechnology

EUROPE INFERTILITY TESTING AND TREATMENT MARKET 2021-2028

Market by Gender, End-user, and Country | Forecast 2021-2028

Request For Customization

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

According to Triton’s report, Europe’s infertility testing and treatment market is estimated to garner a CAGR of 10.25% in revenue during the estimated years of 2021-2028. 


Report scope can be customized per your requirements. Request For Customization

The countries researched in this market include:

•        The United Kingdom

•        Spain

•        Germany

•        Italy

•        France

•        Russia

•        Rest of Europe

In Europe, several fertility clinics have commenced operations, owing to the rising demand for treatments. The market’s growth is primarily due to the late conception. Along with this, the growing awareness pertaining to infertility has increased the demand for infertility testing and treatments. Hence, such developments are likely to support the infertility testing and treatment market’s growth across the region.

In the United Kingdom, there has been a significant rise in infertility rates over the past few years. This is mainly owing to the rise in the aging population and falling fertility rates. Furthermore, the National Health Service funds fertility treatments in various cases, reducing the burden of costs on people. Above all, the country has shown success in IVF treatments, with success rates tripled over the last 20 years. Therefore, supportive government measures and a growing aging population increase the need for infertility treatments, thereby supplementing the progression of the infertility testing and treatment market within the United Kingdom.

Similarly, the rise in infertility rates has influenced the need for infertility treatment across Germany. Factors such as the rising age, development of PCOS, obesity, and multiple miscarriages are also increasing the demand for treatments like IVF. Hence, such factors indicate the growth in demand for infertility testing and treatments, simultaneously propelling the infertility testing and treatment market on a growth path.

EMD Group (Merck KGAA) is a science and technology company known as Merck in other nations except in the US and Canada, where it functions under the name EMD Group. It operates under three business segments, such as healthcare, life science, and performance materials. The company offers prescription medicines for treating cancer, multiple sclerosis, infertility, and others. Besides, it conducts research, offering scientists with lab materials, technologies, and services. EMD operates across various countries, with headquarters in Germany.

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1. EUROPE INFERTILITY TESTING AND TREATMENT MARKET - SUMMARY

2. INDUSTRY OUTLOOK

2.1. KEY INSIGHTS

2.1.1. GROWING DEMAND FOR LOW-COST PROCEDURES

2.1.2. INCREASING ACCEPTANCE OF DONOR EGGS

2.1.3. USE OF AI INCREASES THE SUCCESS OF IVF TREATMENT

2.2. IMPACT OF COVID-19 ON INFERTILITY TESTING AND TREATMENT MARKET

2.3. PORTER’S FIVE FORCES ANALYSIS

2.3.1. THREAT OF NEW ENTRANTS

2.3.2. THREAT OF SUBSTITUTE

2.3.3. BARGAINING POWER OF SUPPLIERS

2.3.4. BARGAINING POWER OF BUYERS

2.3.5. THREAT OF COMPETITIVE RIVALRY

2.4. KEY BUYING IMPACT ANALYSIS

2.4.1. TREATMENT OPTIONS

2.4.2. QUALITY OF MEDICAL PROCEDURES

2.4.3. PRICE OF TREATMENTS

2.4.4. SHIFT TOWARDS MEDICAL TOURISM

2.4.5. REIMBURSEMENT

2.5. MARKET ATTRACTIVENESS MATRIX

2.6. INDUSTRY COMPONENTS

2.6.1. RAW MATERIAL PROCUREMENT

2.6.2. MANUFACTURING

2.6.3. SUPPLY LOGISTICS

2.6.4. DISTRIBUTION CHANNELS

2.6.5. END-USERS

2.7. VENDOR SCORECARD

2.8. KEY MARKET STRATEGIES

2.8.1. CONTRACTS & PARTNERSHIPS

2.8.2. ACQUISITIONS & MERGERS

2.8.3. NEW PRODUCT LAUNCHES

2.9. MARKET DRIVERS

2.9.1. GROWTH IN STRESS AND LIFESTYLE DISORDERS

2.9.2. RISING TRENDS IN DELAYED MARRIAGES AND PREGNANCIES

2.9.3. IMPROVEMENTS IN TREATMENTS

2.9.4. GOVERNMENT SUPPORT

2.10. MARKET CHALLENGES

2.10.1. HIGH COST

2.10.2. SOCIAL TABOO PERTAINING TO INFERTILITY

2.10.3. RISKS ASSOCIATED WITH TREATMENTS

2.11. MARKET OPPORTUNITIES

2.11.1. TECHNOLOGY ADVANCEMENTS IN TIME-LAPSE TECHNOLOGY

2.11.2. ADVANCES IN EMBRYO BIOPSY AND GENETIC SCREENING

3. EUROPE INFERTILITY TESTING AND TREATMENT MARKET – BY GENDER

3.1. MALE

3.1.1. MALE INFERTILITY TESTING

3.1.1.1. DNA FRAGMENTATION

3.1.1.2. OXIDATIVE STRESS ANALYSIS

3.1.1.3. SPERM PENETRATION ASSAY

3.1.1.4. COMPUTER-ASSISTED SEMEN ANALYSIS (CASA)

3.1.1.5. SPERM AGGLUTINATION

3.1.1.6. MICROSCOPIC EXAMINATION

3.1.1.7. OTHERS

3.1.2. MALE INFERTILITY TREATMENT

3.1.2.1. MEDICATION

3.1.2.2. ASSISTED REPRODUCTIVE TECHNOLOGY & VARICOCELE SURGERY

3.2. FEMALE

3.2.1. FEMALE INFERTILITY TESTING

3.2.1.1. OVULATION TESTING

3.2.1.2. HYSTEROSALPINGOGRAPHY

3.2.1.3. LAPAROSCOPY

3.2.1.4. TRANSVAGINAL ULTRASOUND

3.2.1.5. OVARIAN RESERVE TESTING

3.2.1.6. HORMONAL LEVEL TESTING

3.2.1.7. OTHERS

3.2.2. FEMALE INFERTILITY TREATMENT

3.2.2.1. IVF WITH ICSI

3.2.2.2. IUI

3.2.2.3. IVF WITHOUT ICSI

3.2.2.4. SURROGACY

3.2.2.5. THERS

4. EUROPE INFERTILITY TESTING AND TREATMENT MARKET - BY END-USER

4.1. FERTILITY AND SURGICAL CENTERS

4.2. HOSPITALS & RESEARCH LABORATORIES

4.3. CRYOBANKS

5. EUROPE INFERTILITY TESTING AND TREATMENT MARKET – REGIONAL OUTLOOK

5.1. UNITED KINGDOM

5.2. GERMANY

5.3. FRANCE

5.4. SPAIN

5.5. ITALY

5.6. RUSSIA

5.7. REST OF EUROPE

6. COMPETITIVE LANDSCAPE

6.1. ADORFEM

6.2. BANGKOK IVF CENTER

6.3. COOK MEDICAL INC

6.4. COOPER SURGICAL

6.5. CREATE FERTILITY CENTRE

6.6. EMD GROUP (MERCK KGAA)

6.7. ENDO INTERNATIONAL PLC

6.8. FERRING PHARMACEUTICALS

6.9. HALOTECH DNA

6.10. GENEA LTD

6.11. FUJIFILM IRVINE SCIENTIFIC

6.12. VITROLIFE AB

6.13. LABOTECT GMBH

6.14. OLYMPUS CORPORATION

6.15. PROGYNY

7. METHODOLOGY & SCOPE

7.1. RESEARCH SCOPE & DELIVERABLES

7.2. SOURCES OF DATA

7.3. RESEARCH METHODOLOGY

List of Tables

TABLE 1: EUROPE INFERTILITY TESTING AND TREATMENT MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

TABLE 2: MARKET ATTRACTIVENESS MATRIX

TABLE 3: VENDOR SCORECARD

TABLE 4: LIST OF CONTRACTS & PARTNERSHIPS

TABLE 5: LIST OF ACQUISITIONS & MERGERS

TABLE 6: LIST OF NEW PRODUCT LAUNCHES

TABLE 7: AVERAGE COST COMPARISON OF INFERTILITY TREATMENTS

TABLE 8: EUROPE INFERTILITY TESTING AND TREATMENT MARKET, BY GENDER, 2021-2028 (IN $ MILLION)

TABLE 9: EUROPE INFERTILITY TESTING AND TREATMENT MARKET, BY MALE, 2021-2028 (IN $ MILLION)

TABLE 10: EUROPE INFERTILITY TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TESTING, 2021-2028 (IN $ MILLION)

TABLE 11: ROS AND CONS OF DNA SHARING METHODS

TABLE 12: EUROPE INFERTILITY TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TREATMENT, 2021-2028 (IN $ MILLION)

TABLE 13: EUROPE INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE, 2021-2028 (IN $ MILLION)

TABLE 14: EUROPE INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TESTING, 2021-2028 (IN $ MILLION)

TABLE 15: EUROPE INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TREATMENT, 2021-2028 (IN $ MILLION)

TABLE 16: EUROPE INFERTILITY TESTING AND TREATMENT MARKET, BY END-USER, 2021-2028 (IN $ MILLION)

TABLE 17: EUROPE INFERTILITY TESTING AND TREATMENT MARKET, BY COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

List of Figures

FIGURE 1: PORTER’S FIVE FORCES ANALYSIS

FIGURE 2: KEY BUYING IMPACT ANALYSIS

FIGURE 3: INDUSTRY COMPONENTS

FIGURE 4: EUROPE INFERTILITY TESTING AND TREATMENT MARKET, BY GENDER, 2020 & 2028 (IN %)

FIGURE 5: EUROPE INFERTILITY TESTING AND TREATMENT MARKET, BY MALE, 2021-2028 (IN $ MILLION)

FIGURE 6: EUROPE INFERTILITY TESTING AND TREATMENT MARKET, BY MALE, 2020 & 2028 (IN %)

FIGURE 7: EUROPE INFERTILITY TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TESTING, 2021-2028 (IN $ MILLION)

FIGURE 8: EUROPE INFERTILITY TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TESTING, 2020 & 2028 (IN %)

FIGURE 9: EUROPE INFERTILITY TESTING AND TREATMENT MARKET, BY DNA FRAGMENTATION, 2021-2028 (IN $ MILLION)

FIGURE 10: CAUSES OF SPERM DNA FRAGMENTATION

FIGURE 11: EUROPE INFERTILITY TESTING AND TREATMENT MARKET, BY OXIDATIVE STRESS ANALYSIS, 2021-2028 (IN $ MILLION)

FIGURE 12: EUROPE INFERTILITY TESTING AND TREATMENT MARKET, BY SPERM PENETRATION ASSAY, 2021-2028 (IN $ MILLION)

FIGURE 13: EUROPE INFERTILITY TESTING AND TREATMENT MARKET, BY COMPUTER-ASSISTED SEMEN ANALYSIS (CASA), 2021-2028 (IN $ MILLION)

FIGURE 14: EUROPE INFERTILITY TESTING AND TREATMENT MARKET, BY SPERM AGGLUTINATION, 2021-2028 (IN $ MILLION)

FIGURE 15: EUROPE INFERTILITY TESTING AND TREATMENT MARKET, BY MICROSCOPIC EXAMINATION, 2021-2028 (IN $ MILLION)

FIGURE 16: EUROPE INFERTILITY TESTING AND TREATMENT MARKET, BY OTHERS, 2021-2028 (IN $ MILLION)

FIGURE 17: EUROPE INFERTILITY TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TREATMENT, 2021-2028 (IN $ MILLION)

FIGURE 18: EUROPE INFERTILITY TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TREATMENT, 2020 & 2028 (IN %)

FIGURE 19: EUROPE INFERTILITY TESTING AND TREATMENT MARKET, BY MEDICATION, 2021-2028 (IN $ MILLION)

FIGURE 20: EUROPE INFERTILITY TESTING AND TREATMENT MARKET, BY ASSISTED REPRODUCTIVE TECHNOLOGY & VARICOCELE SURGERY, 2021-2028 (IN $ MILLION)

FIGURE 21: EUROPE INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE, 2021-2028 (IN $ MILLION)

FIGURE 22: EUROPE INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE, 2020 & 2028 (IN %)

FIGURE 23: EUROPE INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TESTING, 2021-2028 (IN $ MILLION)

FIGURE 24: EUROPE INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TESTING, 2020 & 2028 (IN %)

FIGURE 25: EUROPE INFERTILITY TESTING AND TREATMENT MARKET, BY OVULATION TESTING, 2021-2028 (IN $ MILLION)

FIGURE 26: EUROPE INFERTILITY TESTING AND TREATMENT MARKET, BY HYSTEROSALPINGOGRAPHY, 2021-2028 (IN $ MILLION)

FIGURE 27: EUROPE INFERTILITY TESTING AND TREATMENT MARKET, BY LAPAROSCOPY, 2021-2028 (IN $ MILLION)

FIGURE 28: EUROPE INFERTILITY TESTING AND TREATMENT MARKET, BY TRANSVAGINAL ULTRASOUND, 2021-2028 (IN $ MILLION)

FIGURE 29: EUROPE INFERTILITY TESTING AND TREATMENT MARKET, BY OVARIAN RESERVE TESTING, 2021-2028 (IN $ MILLION)

FIGURE 30: EUROPE INFERTILITY TESTING AND TREATMENT MARKET, BY HORMONAL LEVEL TESTING, 2021-2028 (IN $ MILLION)

FIGURE 31: EUROPE INFERTILITY TESTING AND TREATMENT MARKET, BY OTHERS, 2021-2028 (IN $ MILLION)

FIGURE 32: EUROPE INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TREATMENT, 2021-2028 (IN $ MILLION)

FIGURE 33: EUROPE INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TREATMENT, 2020 & 2028

FIGURE 34: EUROPE INFERTILITY TESTING AND TREATMENT MARKET, BY IVF WITH ICSI, 2021-2028 (IN $ MILLION)

FIGURE 35: EUROPE INFERTILITY TESTING AND TREATMENT MARKET, BY IUI, 2021-2028 (IN $ MILLION)

FIGURE 36: EUROPE INFERTILITY TESTING AND TREATMENT MARKET, BY IVF WITHOUT ICSI, 2021-2028 (IN $ MILLION)

FIGURE 37: EUROPE INFERTILITY TESTING AND TREATMENT MARKET, BY SURROGACY, 2021-2028 (IN $ MILLION)

FIGURE 38: EUROPE INFERTILITY TESTING AND TREATMENT MARKET, BY OTHERS, 2021-2028 (IN $ MILLION)

FIGURE 39: EUROPE INFERTILITY TESTING AND TREATMENT MARKET, BY END-USER, 2020 & 2028 (IN %)

FIGURE 40: EUROPE INFERTILITY TESTING AND TREATMENT MARKET, BY FERTILITY AND SURGICAL CENTERS, 2021-2028 (IN $ MILLION)

FIGURE 41: EUROPE INFERTILITY TESTING AND TREATMENT MARKET, BY HOSPITALS & RESEARCH LABORATORIES, 2021-2028 (IN $ MILLION)

FIGURE 42: EUROPE INFERTILITY TESTING AND TREATMENT MARKET, BY CRYOBANKS, 2021-2028 (IN $ MILLION)

FIGURE 43: EUROPE INFERTILITY TESTING AND TREATMENT MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

FIGURE 44: UNITED KINGDOM INFERTILITY TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)

FIGURE 45: GERMANY INFERTILITY TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)

FIGURE 46: FRANCE INFERTILITY TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)

FIGURE 47: SPAIN INFERTILITY TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)

FIGURE 48: ITALY INFERTILITY TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)

FIGURE 49: RUSSIA INFERTILITY TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)

FIGURE 50: REST OF EUROPE INFERTILITY TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying